Department of Innovation Science, School of Environment and Society, Tokyo Institute of Technology, Meguro-ku, Tokyo, Japan.
School of Data Science, Nagoya City University, Nagoya, Japan.
Drug Discov Today. 2023 Jul;28(7):103611. doi: 10.1016/j.drudis.2023.103611. Epub 2023 May 8.
Pharmaceutical companies face challenges in business continuity resulting from declining research and development productivity. This study examines the relationship between two strategic pillars: region and therapeutic area, while considering company size. The results indicate that a therapeutic area focus is an effective strategy for small/medium-sized companies, whereas a regional focus is effective for larger companies. These findings highlight the limitations of the traditional global pharmaceutical model from 2004 to 2018 and aim to contribute to the future corporate strategic planning of these companies.
制药公司在业务连续性方面面临挑战，原因是研发生产力下降。本研究考察了两个战略支柱（区域和治疗领域）之间的关系，并考虑了公司规模。结果表明，治疗领域的重点是中小型公司的有效策略，而区域重点则对大公司有效。这些发现突显了 2004 年至 2018 年传统全球制药模式的局限性，并旨在为这些公司的未来企业战略规划做出贡献。
